M89.00
Algoneurodystrophy, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Algoneurodystrophy, also known as Complex Regional Pain Syndrome (CRPS), is a chronic pain condition that typically develops after an injury or trauma. The term 'unspecified site' indicates that the condition affects a part of the body without a clearly defined location. This condition is characterized by prolonged or excessive pain, along with changes in skin color, temperature, and swelling in the affected area. Although the exact cause remains unclear, it is believed to involve abnormal responses of the nervous system to injury, leading to persistent pain and other symptoms.
Causes & Symptoms
Clinical Causes: Trauma or injury, such as fractures, burns, or surgeries Nerve damage or nerve injury Immobilization of a limb after injury or surgery Infections or autoimmune conditions that may trigger nerve responses Rarely, conditions like myocardial infarction or stroke
Key Symptoms: Intense burning or aching pain in the affected area Sensitivity to touch or cold (allodynia and hyperalgesia) Swelling and stiffness in the affected limb or area Changes in skin color, which can be pale, bluish, or red Temperature changes, with the area feeling warmer or cooler than surrounding skin Changes in hair and nail growth patterns Muscle weakness, atrophy, or tremors Dystrophic changes, including hair loss or skin thinning
Diagnostic & Treatment
Diagnosis Path: Diagnosis of algoneurodystrophy involves a thorough medical history and physical examination. Healthcare providers may perform the following assessments:
Treatment Protocols: While there is no one-size-fits-all treatment for algoneurodystrophy, management strategies aim to reduce pain and improve function:
Clinical Advice & FAQs
Billing Guidance
Is M89.00 a billable ICD-10 code?
Yes, M89.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M89.00?
Clinical documentation must specify the nature of Algoneurodystrophy, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference